openPR Logo
Press release

Hemodialysis Access Graft Market trend, outlook 2025

06-26-2018 05:41 PM CET | Health & Medicine

Press release from: Coherent Market Insights Biotechnology

Hemodialysis is one among the three renal replacement therapies used for extracorporeal separation of waste components from the blood in case of kidney failure. Hemodialysis access, also known as vascular access, is a way to access blood for hemodialysis, which can be obtained by three different ways, a fistula, a graft, and a catheter. Hemodialysis access graft are the U-shaped plastic tube used for hemodialysis, which join an artery and veins under the skin of the patient’ arms. Hemodialysis access graft are used in patients with blocked or damaged veins, in which fistula cannot be used. However, hemodialysis access graft do not last as long as fistula, which is expected to be the major factor restraining the hemodialysis access graft market growth. On the other hand, factors that are expected to drive growth include increasing product approvals and rising incidence of chronic kidney disorders. For instance, according to Centers for Disease Control and Prevention (CDC) 2017 factsheet, 30 million people, which comprises 15% of the U.S. adults are estimated to have chronic kidney disease.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1840
Hemodialysis Access Graft Market Dynamics
Novel product launches by market players is a major factor expected to fuel growth the hemodialysis access graft market over the forecast period. For instance, in 2013, CryoLife, Inc., received CE mark for the HeRO Graft, for patients with failing fistulas or blocked veins leading to heart. The company claims HeRO graft as the only fully subcutaneous AV access solution. In 2013, Gore & Associates, launched Gore Acuseal vascular graft for vascular access. The key feature of Gore Acuseal vascular graft is it provides early cannulation i.e. within 24 hours of post-implantation, owing to its trilayer design with low-bleed elastomeric membrane sandwiched between two expanded polytetrafluoroethylene layers. Various companies are adopting trilayer design to sustain in the hemodialysis access graft market. Thus, this can be a growth opportunity for emerging and new entrants in the market.
Increasing incidence of end stage renal disease and other kidney related disorders is a major factor driving growth of the hemodialysis access graft market. According to Centers for Disease Control and Prevention (CDC) factsheet 2017, in 2014, the number of people undergoing treatment for end stage renal diseases were 118,000 in the U.S. and 662,000 were surviving on chronic dialysis or with kidney transplant. According to University of California, 2013, end stage renal disease is increasing by 5% per year in the U.S. In 2013, according to The Renal Association UK Renal Registry, around 57,000 adults in the U.K. were on treatment for kidney failure of which 42% were receiving hemodialysis.
Hemodialysis Access Graft Market - Regional Analysis
Regional segmentation of hemodialysis access graft market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America hemodialysis access graft market is expected to hold a dominant position over the forecast period. This is owing to high prevalence of kidney failure in the region. For instance, according to National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), 2015, in America, around 661,000 Americans suffer from kidney failure, of which 468,000 individuals are on dialysis. However, Asia Pacific hemodialysis access graft market is expected to witness fastest growth, due to large patient pool suffering from diabetes, which increases the chances of renal failure. According to World Health Organization (WHO) 2017 bulletin, South-East Asian population is exhibiting drastic increase in prevalence of diabetes. For instance, the prevalence of diabetes was 46,903,000 in year 2000, which is expected to be 119,541,000 by 2030. This is expected to create a conducive environment for growth of the market in the region.

Request for TOC :  https://www.coherentmarketinsights.com/ongoing-insight/toc/1840
Hemodialysis Access Graft Market – Competitive Analysis
Key players operating in the global hemodialysis access graft market are W.L. Gore & Associated, C. R. Bard, Merit Medical Systems, Inc. and Getinge Group.
Companies are focusing on acquiring complementary business or products to enter the market. For instance, in 2016, Merit Medical Systems, Inc., a manufacturer and marketer of proprietary disposable medical devices used for interventional and diagnostic procedures, acquired HeRO Graft and its related assets from Cryolife, Inc., for US$ 18.5 million. Furthermore, in 2011, Atrium Medical was acquired by Getinge Group for US$ 680 million. The acquisition of Atrium is a strategic move by Getinge Group to leverage scientific and technological advances of both the companies and company will also get access to vascular grafts of Atrium Medical.
Hemodialysis Access Graft Market Taxonomy
Based on material:
Biological Grafts
Synthetic Grafts
Biosynthetic Grafts
Based on end user:
Hospitals
Dialysis centers
Ambulatory Surgical Centers
Clinics
Home Care Settings
Based on region:
North America
Europe
Latin America
Asia Pacific
Middle East
Africa

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemodialysis Access Graft Market trend, outlook 2025 here

News-ID: 1098908 • Views: 614

More Releases from Coherent Market Insights Biotechnology

Wound Care Biologics Market 2026: Global Industry Insights And Growth Analysis B …
Wound care biologic products facilitates in innate repair mechanisms, and involves the use of active biological agents such as animal and plant-derived active biomolecules, which exhibit antioxidant, antimicrobial, or anti-inflammatory properties. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Biologic skin substitute products
Bone Marrow Transplant Market 2018 With Major Key Players STEMCELL Technologies, …
Bone marrow transplant is a medical procedure to replace bone marrow damaged or destroyed by disease, infection, or chemotherapy. Bone marrow transplant procedure involves transplanting blood stem cells that travel to the bone marrow where they produce new blood cells and promote growth of new marrow. Bone marrow is the spongy, fatty tissue inside human bones, which creates the different parts of blood such as red blood cells that carry
Targeted Cancer Therapies Market Future and Technological Advancement To 2026 Wi …
Targeted cancer therapies are drugs which block the growth and proliferation of cancer by interfering with specific molecules such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. Targeted cancer therapies differ in several ways from standard chemotherapy. Standard chemotherapy act on all rapidly dividing cancerous cells as well as normal cells, while targeted cancer therapies act on specific molecular targets that are associated
Insulin Biosimilars Market Size, Growth and SWOT Analysis by Key Players Boehrin …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million

All 5 Releases


More Releases for Graft

Glass Graft Polyols Market 2019| BASF SE, Sinopec, Shell, Oltchim, The Dow Chemi …
Market Research Hub (MRH) has actively included a new research study titled “Global Graft Polyols Market” Research Report 2019 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period limit; 2025. In
Dental Bone Graft and Substitutes Market Insights
Bone graft materials are available in varieties such as allografts, xenografts, and synthetic substitutes and can be custom made according to the need of the patient, which makes it convenient for both, the physician and patient driving the growth of the market. Bone grafts are widely available from various sources such as from patients, from another donor, from animal sources, or are synthetically made. Furthermore, advancements in technology has led
Innovation in Bone Graft Techniques Drives the Global Dental Membrane and Bone G …
Dental membrane and bone graft substitutes is used in the bone graft surgeries. Bone graft surgery is required when tooth is lost by accidents, dental disease and old age. According to WHO, Globally, about 30% of people aged 65–74 have no natural teeth and Across the world, 16-40% of children in the age range 6 to12 years old are affected by dental trauma due to unsafe playgrounds, unsafe schools, road
Global Bone Graft Substitutes Market snapshot 2027
- To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Global Bone Graft Substitutes Market - To provide insights about factors affecting the market growth - To Analyze the Global Bone Graft Substitutes Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1195 - To provide historical and
Vascular Graft Market Shows Highest Growth Potential
Vascular surgical procedure remains often invasive and needs prolonged hospital stays. Conventional vascular surgery comprises of opening the body, cutting vessels, and closing it by means of sutures, it consist of procedures such as carotid endarterectomy, open abdominal aneurysm repair and lower extremity bypass surgery. In contrast, majority of vascular graft procedures are usually are minimally invasive besides involve repairing vessels from inside. Catheter-based devices are introduced through a minor
03-15-2017 | Health & Medicine
TMR
Innovation in Bone Graft Techniques Drives the Global Dental Membrane and Bone G …
Dental membrane and bone graft substitutes is used in the bone graft surgeries. Bone graft surgery is required when tooth is lost by accidents, dental disease and old age. According to WHO, Globally, about 30% of people aged 65–74 have no natural teeth and Across the world, 16-40% of children in the age range 6 to12 years old are affected by dental trauma due to unsafe playgrounds, unsafe schools, road